BioXcel Therapeutics, Inc. (BTAI) Analyst Estimates Annual - Discounting Cash Flows
BTAI
BioXcel Therapeutics, Inc.
BTAI (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
Number of Analysts 1 1 1 3 2 3 8 2
Estimated Revenue
Low 142 81.52 15.49 1.44 0.303 1.11 1.22 0.824
Average 281.6 161.6 30.7 2.86 0.6 2.21 1.71 1.18
High 462.8 265.6 50.46 4.7 0.986 3.63 3.04 1.74
Estimated EBITDA
Low -92.56 -53.12 -10.09 -0.94 -0.197 -0.726 -0.609 0.165
Average -56.32 -32.32 -6.14 -0.572 -0.12 -0.442 -0.343 0.236
High -28.41 -16.3 -3.1 -0.289 -0.061 -0.223 -0.244 0.349
Estimated EBIT
Low -92.56 -53.12 -10.09 -0.94 -0.197 -0.726 -0.609 0.165
Average -56.32 -32.32 -6.14 -0.572 -0.12 -0.442 -0.343 0.236
High -28.41 -16.3 -3.1 -0.289 -0.061 -0.223 -0.244 0.349
Estimated Net Income
Low 0.478 -5.07 -9.73 -10.36 -18.8 -64.7 -439.7 -245.4
Average 1.34 -2.76 -5.81 -7.71 -16.5 -62.84 -107.8 -151.4
High 2.47 -0.983 -1.88 -5.06 -14.21 -60.99 -85.17 -91.92
Estimated SGA Expenses
Low 7,416 4,256 808.5 75.34 15.8 58.19 63.57 40.67
Average 14,701 8,436 1,603 149.4 31.32 115.4 89.53 58.29
High 24,162 13,866 2,634 245.5 51.48 189.6 158.9 86.1
Estimated EPS
Low 0.189 -2 -3.84 -4.09 -7.42 -25.52 -173.5 -8.42
Average 0.53 -1.09 -2.09 -3.04 -6.51 -24.87 -94.44 -5.2
High 0.973 -0.388 -0.744 -1.99 -5.6 -24.06 -33.6 -3.16
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program